All Stories

  1. Performance of the proposed ASAS/SPARTAN classification criteria in a cohort of patients with acute anterior uveitis and newly diagnosed axial spondyloarthritis
  2. Supplementary Figure S1 from High-Resolution Anoscopy Referral Rates Adopting Different Anal Cancer Screening Strategies for Men Who Have Sex with Men
  3. Increasing cervical screening uptake in women with intellectual and developmental disabilities requires risk-proportionate, rights-based approaches beyond individual-level interventions
  4. Population‐Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening
  5. The co-creation of a document to guide the use of self-sampling for human papillomavirus screening in Italy
  6. Conservative Management of CIN2 Within Primary HPV Cervical Cancer Screening Programme: A Cohort Study
  7. Polygenic risk score-enhanced breast cancer screening: recommendations for European health systems 2025
  8. Assessing COVID-19 Infection and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern Italy
  9. Data from Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study
  10. Supplementary Figure from Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study
  11. Assessing COVID-19 Infection, and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern Italy
  12. Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology
  13. Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology
  14. Inverse Association of Longitudinal Variations in Fat Tissue Radiodensity and Area
  15. Challenges and Opportunities for Global Cervical Cancer Elimination: How Can We Build a Model for Other Cancers?
  16. A COVID-19-Dedicated Facility for the Care of Older Adults During a Health Emergency: An Italian Experience
  17. Data from High-Resolution Anoscopy Referral Rates Adopting Different Anal Cancer Screening Strategies for Men Who Have Sex with Men
  18. Supplementary Figure S1 from High-Resolution Anoscopy Referral Rates Adopting Different Anal Cancer Screening Strategies for Men Who Have Sex with Men
  19. The Tdap Vaccination in Pregnancy: Results of a Healthy Equity Audit on Coverage Trends and Their Determinants in the Reggio Emilia Province (Italy)
  20. High-Resolution Anoscopy Referral Rates Adopting Different Anal Cancer Screening Strategies for Men Who Have Sex with Men
  21. Validating the Core Set for Vocational Rehabilitation in a Population of Cancer Survivors: A Cross-Sectional Study
  22. Behaviours as biomarkers? Disentangling causality between vitamin D, sedentary behaviours and mortality is necessary for preventing recurrence and cardiovascular disease in cancer survivors
  23. Sleep quality worsens over the first year after breast cancer diagnosis
  24. What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries
  25. Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries
  26. Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?
  27. Eosinophilic giant cell arteritis: A different subset of disease?
  28. Cardiovascular risk and access to primary care: Comparisons among Chinese documented and undocumented immigrants
  29. Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply
  30. Accuracy of World Health Organisation‐grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study
  31. Comparing accuracy of tomosynthesis plus digital mammography or synthetic 2D mammography in breast cancer screening: baseline results of the MAITA RCT consortium
  32. Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: The four-way decomposition analysis
  33. CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection
  34. European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study
  35. Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study
  36. A cohort study on the biochemical and haematological parameters of Italian blood donors as possible risk factors of COVID-19 infection and severe disease in the pre- and post-Omicron period
  37. Recruitment strategies and interventions to increase participation in lung cancer screening programmes: a systematic review protocol
  38. Motivation, acceptability and attitudes toward lung cancer screening among persons who attend a tobacco cessation program: A multicenter survey in Italy
  39. SARS-CoV-2 transmission patterns in educational settings during the Alpha wave in Reggio-Emilia, Italy
  40. High temperature, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances
  41. Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study
  42. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
  43. Excluding specificity from research and development priorities is delaying the AI adoption in breast cancer screening
  44. Elements Characterising Multicomponent Interventions Used to Improve Disease Management Models and Clinical Pathways in Acute and Chronic Heart Failure: A Scoping Review
  45. Study of the impact of the procedure and donor features on plasma donation
  46. Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
  47. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases
  48. The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy
  49. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022
  50. Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: the four-way decomposition analysis
  51. The effect of diabetes on COVID-19 incidence and mortality: Differences between highly-developed-country and high-migratory-pressure-country populations
  52. Residential exposure to air pollution and adverse respiratory and allergic outcomes in children and adolescents living in a chipboard industrial area of Northern Italy
  53. Activities Carried Out during the First COVID-19 Lockdown by Italian Citizens
  54. HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions
  55. The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020
  56. The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development
  57. Abdominal Fat Characteristics and Mortality in Rectal Cancer: A Retrospective Study
  58. Association between short-term exposure to air pollutants and cause-specific daily mortality in Italy. A nationwide analysis
  59. Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data
  60. Heat wave, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances
  61. Incidence of malignant mesothelioma and asbestos exposure in the Emilia-Romagna region, Italy
  62. Surveillance, contact tracing and characteristics of SARS-CoV-2 transmission in educational settings in Northern Italy, September 2020 to April 2021
  63. Effectiveness of mobile health interventions targeting parents to prevent and treat childhood Obesity: Systematic review
  64. Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study
  65. The epidemiology of oral cancer during the COVID-19 pandemic in Northern Italy: Incidence, survival, prevalence
  66. Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study
  67. What a woman needs to know about overdiagnosis to decide about breast cancer screening
  68. Diabetes and COVID-19 testing, positivity, and mortality: A population-wide study in Northern Italy
  69. Exhaled breath condensate proteomic signatures potentially distinguish adenocarcinoma from benign cystic lesions of the pancreas
  70. The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys
  71. A COVID-19-Dedicated Facility for the Care of Older Adults During a Health Emergency: An Italian Experience
  72. A deep learning approach for Spatio-Temporal forecasting of new cases and new hospital admissions of COVID-19 spread in Reggio Emilia, Northern Italy
  73. Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission
  74. Patient-centred care with self-compression mammography in clinical practice: a randomized trial compared to standard compression
  75. Validation of the Italian version of the Tool to Measure Parenting Self‐Efficacy questionnaire using data from an intervention study
  76. Incidence and Characteristics of Adverse Events after COVID-19 Vaccination in a Population-Based Programme
  77. Specific miRNAs Change After 3 Months of GH treatment and Contribute to Explain the Growth Response After 12 Months
  78. Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy
  79. Imaging-based indices combining disease severity and time from disease onset to predict COVID-19 mortality: A cohort study
  80. Quality appraisal of documents producing recommendations for breast, colorectal and cervical cancer screening
  81. Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial
  82. Impact of Insulin Therapies on Cancer Incidence in Type 1 and Type 2 Diabetes: A Population-Based Cohort Study in Reggio Emilia, Italy
  83. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial
  84. A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone
  85. Fusion radiology in interventional endoscopy (FRIend): a new approach for pancreatic fluid collections
  86. Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist
  87. Clinical Epidemiology of Microinvasive Cervical Carcinoma in an Italian Population Targeted by a Screening Programme
  88. How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study
  89. Clinical and imaging characteristics of patients with COVID-19 predicting hospital readmission after emergency department discharge: a single-centre cohort study in Italy
  90. Adaptation of the Core Set for Vocational Rehabilitation for Cancer Survivors: A Qualitative Consensus-Based Study
  91. Return to work of Italian cancer survivors: A focus on prognostic work-related factors
  92. Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients
  93. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis
  94. Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study
  95. Photodynamic therapy for superficial basal cell carcinomas: Clinical features of partial responses and recurrences
  96. The IARC Perspective on Cervical Cancer Screening
  97. Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018
  98. Abstract OT2-10-02: Mypebs: An international randomized study comparing personalized, risk-stratified to standard breast cancer screening in women aged 40-70
  99. Barriers to Accessing Primary Care and Appropriateness of Healthcare Among Immigrants in Italy
  100. A nationwide study of air pollution from particulate matter and daily hospitalizations for respiratory diseases in Italy
  101. The impact of COVID‐19 on new mesothelioma diagnoses in Italy
  102. Correction to: Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  103. Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic
  104. Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study
  105. General and COVID-19-Related Mortality by Pre-Existing Chronic Conditions and Care Setting during 2020 in Emilia-Romagna Region, Italy
  106. Exploring the evidence for the effectiveness of health interventions for COVID-19 targeting migrants: a systematic review protocol
  107. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  108. A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients
  109. The IARC Perspective on Cervical Cancer Screening
  110. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population
  111. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer
  112. A microscale hybrid modelling system to assess the air quality over a large portion of a large European city
  113. Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk
  114. Secondary transmission of SARS-CoV-2 in educational settings in Northern Italy from September 2020 to April 2021: a population-based study
  115. Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68–69
  116. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study
  117. Corrigendum to: p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
  118. Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study
  119. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study
  120. The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre
  121. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3
  122. Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  123. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients
  124. Colon cancer survival differs from right side to left side and lymph node harvest number matter
  125. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room
  126. Beyond Lockdown: The Potential Side Effects of the SARS-CoV-2 Pandemic on Public Health
  127. The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis
  128. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
  129. Cumulative COVID ‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy
  130. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy
  131. Effectiveness of mobile health interventions targeting parents to prevent and treat childhood obesity: a systematic review (Preprint)
  132. Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix
  133. GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
  134. Impact of multidisciplinary approach and radiologic review on surgical outcome and overall survival of patients with pancreatic cancer: a retrospective cohort study
  135. Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients
  136. Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
  137. Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
  138. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer
  139. Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes
  140. Guideline-based quality assurance: a conceptual framework for the definition of key elements
  141. Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative
  142. The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients
  143. Optimising plasmapheresis procedure: The role of plasma unit weight setting
  144. Using text analysis software to identify determinants of inappropriate clinical question reporting and diagnostic procedure referrals in Reggio Emilia, Italy
  145. Hepatitis C virus cascade of care in the general population, in people with diabetes, and in substance use disorder patients
  146. Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy
  147. Retrospective analysis of the effect on interval cancer rate of adding an artificial intelligence algorithm to the reading process for two-dimensional full-field digital mammography
  148. Poor Sleep during the First Peak of the SARS-CoV-2 Pandemic: A Cross-Sectional Study
  149. Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy
  150. Development of evidence-based guidelines for follow up of women treated for cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) in Italian screening programmes
  151. Systematic review of existing guidelines for NAFLD assessment
  152. Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study
  153. Breast cancer screening: in the era of personalized medicine, age is just a number
  154. <p>Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network</p>
  155. Susceptibility to COVID‐19 in Patients Treated With Antimalarials: A Population‐Based Study in Emilia‐Romagna, Northern Italy
  156. Development and first application of an audit system for screening programs based on the PRECEDE-PROCEED model: an experience with breast cancer screening in the region of Lombardy (Italy)
  157. Cumulative COVID-19 incidence, mortality, and prognosis in cancer survivors: a population-based study in Reggio Emilia, Northern Italy
  158. Secondary transmission of COVID-19 in preschool and school settings after their reopening in northern Italy: a population-based study
  159. Facial palsy during the COVID‐19 pandemic
  160. Five-year relative survival by stage of breast and colon cancers in Italy
  161. Determinants of p16/Ki‐67 adequacy and positivity in HPV‐positive women from a screening population
  162. Knowledge, Opinion, and Attitude About the Italian Law on Advance Directives: A Population-Based Survey
  163. Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive in...
  164. Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
  165. Evaluation of an intervention aimed at supporting new parents: the Baby Newsletter project
  166. Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy
  167. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
  168. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
  169. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study
  170. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
  171. Abdominal Visceral Infarction in 3 Patients with COVID-19
  172. Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy.
  173. SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia
  174. Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy
  175. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
  176. Response to: ‘COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study’ by Cuceoglu et al
  177. Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up
  178. Source-related components of fine particulate matter and risk of adverse birth outcomes in Northern Italy
  179. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement
  180. Personalized early detection and prevention of breast cancer: ENVISION consensus statement
  181. Mowat-Wilson syndrome: growth charts
  182. Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors
  183. Describing the Process and Tools Adopted to Cocreate a Smartphone App for Obesity Prevention in Childhood: Mixed Method Study
  184. Development and use of health outcome descriptors: a guideline development case study
  185. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study
  186. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
  187. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study
  188. Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network
  189. Early life weight patterns and risk of obesity at 5 years: A population-based cohort study
  190. Risk of cancer in individuals with alcohol and drug use disorders: a registry-based study in Reggio Emilia, Italy
  191. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy
  192. Association between Urinary Levels of Aflatoxin and Consumption of Food Linked to Maize or Cow Milk or Dairy Products
  193. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high‐risk human papillomavirus at primary screening
  194. New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, Italy
  195. Epidemiology and biological characteristics of male breast cancer in Italy
  196. HPV screening performance indicators in women who previously tested HPV-negative: The second round of Vallecamonica screening programme, Northern Italy
  197. Interlaboratory concordance of p16/Ki‐67 dual‐staining interpretation in HPV‐positive women in a screening population
  198. Optimization and validation of a LC-HRMS method for aflatoxins determination in urine samples
  199. Temporal Profile and Determinants of Viral Shedding and of Viral Clearance Confirmation on Nasopharyngeal Swabs from SARS-CoV-2-Positive Subjects: A Population-Based Study in Reggio Emilia
  200. A cluster randomized trial to measure the impact on nonsteroidal anti-inflammatory drug and proton pump inhibitor prescribing in Italy of distributing cost-free paracetamol to osteoarthritic patients
  201. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
  202. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme
  203. Risk of CIN2 or more severe lesions after negative HPV‐mRNA E6/E7 overexpression assay and after negative HPV‐DNA test: Concurrent cohorts with a 5‐year follow‐up
  204. Neoadjuvant therapy for breast cancer
  205. Describing the Process and Tools Adopted to Cocreate a Smartphone App for Obesity Prevention in Childhood: Mixed Method Study (Preprint)
  206. Corrigendum to “Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance” [Prev. Med. 120 (2019) 60–70]
  207. The effect of Public Health/Pediatric Obesity interventions on socioeconomic inequalities in childhood obesity: A scoping review
  208. Five‐year risk of CIN3 after short‐term HPV‐DNA negativity in cytology‐negative women: a population‐based cohort study
  209. Correction: Determinants of inappropriate setting allocation in the care of patients with type 2 diabetes: A population-based study in Reggio Emilia province
  210. Methods for Development of the European Commission Initiative on Breast Cancer Guidelines
  211. Determinants of inappropriate setting allocation in the care of patients with type 2 diabetes: A population-based study in Reggio Emilia province
  212. Re: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial
  213. Biomonitoring Data for Assessing Aflatoxins and Ochratoxin A Exposure by Italian Feedstuffs Workers
  214. Factors influencing return to work of cancer survivors: a population-based study in Italy
  215. Accuracy of imaging methods for steatohepatitis diagnosis in non‐alcoholic fatty liver disease patients: A systematic review
  216. CFTR and FOXO1 gene expression are reduced and high mobility group box 1 (HMGB1) is increased in the ovaries and serum of women with polycystic ovarian syndrome
  217. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
  218. Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988–2015. Diabetes Care 2018;41:2306–2315
  219. Annual mammography at age 45–49 years and biennial mammography at age 50–69 years: comparing performance measures in an organised screening setting
  220. Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis
  221. Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance
  222. Comparing two visualization protocols for tomosynthesis in screening: specificity and sensitivity of slabs versus planes plus slabs
  223. Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study
  224. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer
  225. Estimating the impact of an organised screening programme on cervical cancer incidence: A 26‐year study from northern Italy
  226. Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study
  227. Evidence-based screening protocols for cervical cancer?
  228. The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
  229. The impact of blind peer review (team reading) of equivocal/abnormal Papanicolaou smears on inter-reader agreement
  230. Molecular imaging biomarkers for breast cancer risk and personalized screening
  231. Cancer incidence following long-term consumption of drinking water with high inorganic selenium content
  232. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study
  233. Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey
  234. Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study
  235. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial
  236. Cohort profile: the Italian Network of Longitudinal Metropolitan Studies (IN-LiMeS), a multicentre cohort for socioeconomic inequalities in health monitoring
  237. Effectiveness of integrated care model for type 2 diabetes: A population-based study in Reggio Emilia (Italy)
  238. Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing
  239. Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more
  240. Role of HPV DNA testing in modern gynaecological practice
  241. The effects of improving the mesothelioma surveillance network on sensitivity, timeliness in reporting and asbestos exposure assessment
  242. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy
  243. Association between mothers’ screening uptake and daughters’ HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign
  244. Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care
  245. Factors Influencing the Accuracy of Infectious Disease Reporting in Migrants: A Scoping Review
  246. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes
  247. Lifestyle-tailored interventions for South Asians with type 2 diabetes living in high-income countries: a systematic review
  248. Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa)
  249. Mammography screening: please don't be vague, tell me when I should come!
  250. Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
  251. Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy
  252. Effects of the Addition of a Dual Task to a Supervised Physical Exercise Program on Older Adults’ Cognitive Performance
  253. Survey on Urinary Levels of Aflatoxins in Professionally Exposed Workers
  254. Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature
  255. Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round
  256. Changes in Mortality and Incidence of Prostate Cancer by Risk Class in Different Periods in Italy: The Possible Effects of PSA Spread
  257. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy
  258. Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy
  259. Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types
  260. Trends in net survival from kidney cancer in six European Latin countries
  261. Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy
  262. Interobserver reproducibility of cytologic p16INK4a/Ki-67 dual immunostaining in human papillomavirus-positive women
  263. Cognitive Clusters in Specific Learning Disorder
  264. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
  265. Impact of variations in triage cytology interpretation on human papillomavirus–based cervical screening and implications for screening algorithms
  266. Prevalence of Primary HPV in Djibouti
  267. Long-term mortality patterns in a residential cohort exposed to inorganic selenium in drinking water
  268. Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy
  269. Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program
  270. Cervical cancer screening in immigrant women in Italy
  271. Differences in mortality by immigrant status in Italy. Results of the Italian Network of Longitudinal Metropolitan Studies
  272. Diagnostic values of glycated haemoglobin and diagnosis of diabetes: Results of a cross-sectional survey among general practitioners in the province of Reggio Emilia, Italy
  273. Recommendation without experts? Epistemological implications in the development of screening guidelines
  274. Comment on “Incidence of Type 1 Diabetes among Children and Adolescents in Italy between 2009 and 2013: The Role of a Regional Childhood Diabetes Registry”
  275. Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators
  276. Use of Cytology, E6/E7 mRNA, and p16INK4a–Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening
  277. Comparative cyclic tests of exterior flat slab–column connections in normal concrete and fiber-reinforced lightweight aggregate concrete
  278. Motivational Interviewing to Treat Overweight Children: 24-Month Follow-Up of a Randomized Controlled Trial
  279. Letter to the editor: Responding to a call for action - where are we now?
  280. Colorectal cancer screening of immigrants to Italy. Figures from the 2013 National Survey
  281. Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study
  282. Impact of the Introduction of Digital Mammography in an Organized Screening Program on the Recall and Detection Rate
  283. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study
  284. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
  285. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
  286. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5
  287. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study
  288. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods
  289. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5
  290. Towards a European Framework to Monitor Infectious Diseases among Migrant Populations: Design and Applicability
  291. Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion
  292. Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy
  293. Cervical Cancer Screening by Human Papillomavirus Testing Followed by Cytology Triage
  294. Changes in cervical cancer incidence following the introduction of organized screening in Italy
  295. HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs
  296. Cervical cancer epidemiology in foreign women in Northern Italy
  297. Exposure to emissions from municipal solid waste incinerators and miscarriages: A multisite study of the MONITER Project
  298. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter
  299. Screening history of cervical cancers in Emilia-Romagna, Italy
  300. Differences in diabetes prevalence and inequalities in disease management and glycaemic control by immigrant status: a population-based study (Italy)
  301. Corrigendum to “A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomized controlled trial in population-based screening programmes” [Prev. Med. 65 (2014) 70–76]
  302. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
  303. Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
  304. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
  305. Sex Differences in Cardiovascular Mortality in Diabetics and Nondiabetic Subjects: A Population-Based Study (Italy)
  306. Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme
  307. Health care costs and functional outcomes of road traffic injuries in the Lazio region of Italy
  308. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes
  309. Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer
  310. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients
  311. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence
  312. HPV-based screening for prevention of invasive cervical cancer – Authors' reply
  313. Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening
  314. Impact of p16INK4a Immunohistochemistry Staining on Interobserver Agreement on the Diagnosis of Cervical Intraepithelial Neoplasia
  315. Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy
  316. Public and private pregnancy care in Reggio Emilia Province: an observational study on appropriateness of care and delivery outcomes
  317. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
  318. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
  319. The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs
  320. Building a population-based diabetes register: An Italian experience
  321. Occupational Exposure to Physical Agents: The New Italian Database for Risk Assessment and Control
  322. The use of Cincinnati prehospital stroke scale during telephone dispatch interview increases the accuracy in identifying stroke and transient ischemic attack symptoms
  323. Validation and improvement of N1 method for pushover analysis
  324. Effects of immigrant status on Emergency Room (ER) utilisation by children under age one: a population-based study in the province of Reggio Emilia (Italy)
  325. Pediatrician-led Motivational Interviewing to Treat Overweight Children: An RCT
  326. Triage of women with minor abnormal cervical cytology: Meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types
  327. Re: Lead time and down-staging in the survival of cervical cancer cases detected by screening
  328. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer
  329. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: A follow-up study
  330. First results of a new methodology for the identification of road surface anomalies
  331. Clinical Impact of the Analytical Specificity of the Hybrid Capture 2 Test: Data from the New Technologies for Cervical Cancer (NTCC) Study
  332. How socioeconomic status influences road traffic injuries and home injuries in Rome
  333. Increased incidence of thyroid cancer in Latina, Italy: A possible role of detection of subclinical disease
  334. Key factors influencing lung cancer survival in northern Italy
  335. Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
  336. Methods to increase participation in organised screening programs: a systematic review
  337. The Present and Future of Cervical Cancer Screening Programmes in Europe
  338. Prognostic Value of HPV E6/E7 mRNA Assay in Women with Negative Colposcopy or CIN1 Histology Result: A Follow-Up Study
  339. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial
  340. Health Technology Assessment of Computer-Assisted Pap Test Screening in Italy
  341. Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
  342. Weighted‐peak assessment of occupational exposure due to MRI gradient fields and movements in a nonhomogeneous static magnetic field
  343. How to increase uptake in oncologic screening: A systematic review of studies comparing population-based screening programs and spontaneous access
  344. Meta‐analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test
  345. Appropriateness of the Indication for Colonoscopy
  346. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study
  347. HPV Testing Is an Efficient Management Choice for Women With Inadequate Liquid-Based Cytology in Cervical Cancer Screening
  348. Consent for Research With Biological Samples: One-Time General Consent Versus a Gift Model
  349. Early and Mid-Term Clinical Outcome of Emergency PCI in Patients with STEMI due to Unprotected Left Main Coronary Artery Disease
  350. HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
  351. Menometrorrhagia in magnetic resonance imaging operators with copper intrauterine contraceptive devices (IUDS): A case report
  352. A case–control study on risk factors of domestic accidents in an elderly population
  353. Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee:Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical Study
  354. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy
  355. HPV prevalence and accuracy of HPV testing to detect high‐grade cervical intraepithelial neoplasia
  356. Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test
  357. Occupational and environmental exposure to extremely low frequency-magnetic fields: a personal monitoring study in a large group of workers in Italy
  358. Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
  359. HPV types in early-onset cervical cancer
  360. Distribution of high and low risk HPV types by cytological status: a population based study from Italy
  361. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
  362. Exposure to magnetic fields of railway engine drivers: a case study in Italy
  363. Triage and Injury Severity Scores as predictors of mortality and hospital admission for injuries: A validation study
  364. Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
  365. An integrated surveillance system of road traffic injuries in the Lazio region of Italy: results of a 5-year study (2001–2005)
  366. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study
  367. Tailored Screening for Breast Cancer in Premenopausal Women: Not Just Looking at Sensitivity, But Aiming to Reduce Burden
  368. HPV 16/18 vaccines and the impact on organized cervical cancer screening
  369. Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening
  370. End-of-Life Care in Italian Hospitals: Quality of and Satisfaction With Care From the Caregivers' Point of View—Results from the Italian Survey of the Dying of Cancer
  371. Screening for Cervical Cancer with the Human Papillomavirus Test in an Area of Central Italy with No Previous Active Cytological Screening Programme
  372. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy
  373. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
  374. Validity of caregiver-reported hospital admission in a study on the quality of care received by terminally ill cancer patients
  375. Mobile phones exposure induces changes of contingent negative variation in humans
  376. The Reproducibility of CIN Diagnoses Among Different Pathologists
  377. Validating regional Hospital Information System data through comparison with a local cancer register to identify interval cancers of a breast screening program
  378. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
  379. Incidence of bacterial meningitis (2001–2005) in Lazio, Italy: the results of a integrated surveillance system
  380. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy
  381. Health and economic impact associated with a quadrivalent HPV vaccine in Italy
  382. An emergency clinical pathway for stroke patients – results of a cluster randomised trial (isrctn41456865)
  383. The allergic sensitization in infants with atopic eczema from different countries
  384. Road traffic injuries in one local health unit in the Lazio region: results of a surveillance system integrating police and health data
  385. Exposure of Workers to Electromagnetic Fields. A Review of Open Questions on Exposure Assessment Techniques
  386. HPV vaccination and colposcopy workload of screening programmes
  387. New paradigms in cervical cancer prevention: opportunities and risks
  388. Re: Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
  389. Syndromic surveillance: sensitivity and positive predictive value of the case definitions
  390. Early atopic disease and early childhood immunization – is there a link?
  391. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
  392. Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: The experimental and pilot phases of the Lazio program
  393. Do women ⩾50 years of age need as much screening as women <50 years after they have had negative screening results?
  394. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women
  395. Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test
  396. Mortality in elderly injured patients: the role of comorbidities*
  397. No evidence of major transcriptional changes in the brain of mice exposed to 1800 MHz GSM signal
  398. The Risk of False-Positive Histology According to the Reason for Colposcopy Referral in Cervical Cancer Screening
  399. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study
  400. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment
  401. The impact of new technologies in cervical cancer screening: Results of the recruitment phase of a large randomised controlled trial from a public health perspective
  402. Home injuries mortality: Sensitivity and specificity analysis of different data sources and operative definitions
  403. Dying of cancer in Italy: impact on family and caregiver. The Italian Survey of Dying of Cancer
  404. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
  405. Agreement Between Emergency Room and Discharge Diagnoses in a Population of Injured Inpatients: Determinants and Mortality
  406. Inequity in the provision of and access to palliative care for cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)
  407. Streptococcus pneumoniae incidence in western Europe – Authors' reply
  408. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology
  409. Evaluation of the health effects of the new driving penalty point system in the Lazio Region, Italy, 2001-4
  410. Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy
  411. Corrigendum to “Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy” [Prev. Med. 41 (2005) 30–35]
  412. Unintentional home injuries reported by an emergency-based surveillance system: Incidence, hospitalisation rate and mortality
  413. The effect of screening programmes on the treatment of benign breast neoplasms: observations from current practice in Italy
  414. Colorectal cancer screening: Recommendations and guideline adherence by physicians from digestive endoscopy centers in the Lazio region, Italy
  415. Defining a common set of indicators to monitor road accidents in the European Union
  416. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old
  417. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
  418. Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
  419. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)
  420. Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey
  421. Correspondence
  422. Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods
  423. The Role of GPs in Increasing Compliance to Colorectal Cancer Screening: A Randomised Controlled Trial (Italy)
  424. Is the type of test used for mass colorectal cancer screening a determinant of compliance?
  425. Electromagnetic Fields: Principles of Exposure Mitigation
  426. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]
  427. The last three months of life of Italian cancer patients. Methods, sample characteristics and response rate of the Italian Survey of the Dying of Cancer (ISDOC)
  428. In Vitro Evaluation of Biological Effects on Human Keratinocytes Exposed to 900 MHz Electromagnetic Field
  429. A controversial necrotizing enterocolitis outbreak in a neonatal unit
  430. Does a pre-hospital emergency pathway improve early diagnosis and referral in suspected stroke patients? – Study protocol of a cluster randomised trial [ISRCTN41456865]
  431. Road Traffic Injuries in Lazio, Italy: A Descriptive Analysis From an Emergency Department–Based Surveillance System
  432. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy
  433. Trying to improve the compliance to colorectal cancer screening: A complex study design for a complex planning question
  434. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial
  435. Choosing immunisation coverage indicators at the local level
  436. An epidemic of gastroenteritis and mild necrotizing enterocolitis in two neonatal units of a University Hospital in Rome, Italy
  437. Voltage-Operated Calcium Channel Heterogeneity in Pancreatic   Cells: Physiopathological Implications
  438. Outbreaks of food borne diseases in the Lazio region, Italy: The results of epidemiological field investigations
  439. Factors Associated with Hepatitis B Virus Immunization Coverage at the Beginning of a Population Campaign in the Lazio Region, Italy
  440. Timing of Gene Expression and Oolemma Localization of Mouse α6and β1Integrin Subunits during Oogenesis
  441. Meiotic and Developmental Competence of Mouse Antral Oocytes1
  442. Chromatin organization during mouse oocyte growth